Market Cap (In AUD)
267.4 Million
Revenue (In AUD)
194.03 Million
Net Income (In AUD)
15.6 Million
Avg. Volume
1147.00
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.15-3.53
- PE
- -
- EPS
- -
- Beta Value
- 0.373
- ISIN
- NZAFTE0001S4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Hartley Atkinson Ph.D.
- Employee Count
- -
- Website
- https://www.aftpharm.com
- Ipo Date
- 2016-03-14
- Details
- AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.
More Stocks
-
TSCDYTesco PLC
TSCDY
-
SMAWF
-
FSS
-
603396
-
APO
-
CRANESSOFTCranes Software International Limited
CRANESSOFT
-
BRFSBRF S.A.
BRFS
-
CX